GSK宣布，Ceouk Pharmaceuticals Company GSK的惊喜变更使该市感到惊讶，宣布改变首席执行官。EmmaWalmsley将在担任9年的掌舵后辞去首席执行官的辞职，并将被公司内部人员Luke Miels替换。 He will become CEO on 1st January 2026.GSK tells investors:Luke is a highly respected, experienced global biopharma leader, having worked at senior levels in the US, Europe and Asia, at AstraZeneca, Roche and Sanofi-Aventis, prior to joining GSK.This experience, and significant contribution to GSK, mean he is exceptionally well-qualified to lead the company, and to deliver the patient and shareholder value inherent in该公司的未来雄心壮志。 GSK说，米尔斯的任命“反映了董事会和艾玛的有效长期继承计划”，并考虑了一系列候选人，内部和外部的候选人。在她的九年中，沃尔姆斯利（Walmsley）一直在对GSK进行了广泛的大修，包括将其消费者卫生业务旋转为新公司，成为一家新公司，Haleon。